Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arin Nam

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Seminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.
Cell Reports. Medicine|February 1, 2021
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, et al.
Journal of Clinical Medicine|August 6, 2020
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational ResearchShanmuga Subbiah, Arin Nam, Natasha Garg, et al.
Expert Opinion on Investigational Drugs|March 18, 2020
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trialsAtish Mohanty, Rebecca R Pharaon, Arin Nam, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Oncotarget|May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patientsValeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
JAMA Oncology|November 27, 2024
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A ReviewJyoti Malhotra, Isa Mambetsariev, Gregory Gilmore, et al.
Cancer Research|April 8, 2024
Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic PlasticityArin Nam, Shashi Jain, Chengsheng Wu, et al.
Iscience|November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell CarcinomasSaumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Seminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.
Cell Reports. Medicine|February 1, 2021
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, et al.
Journal of Clinical Medicine|August 6, 2020
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational ResearchShanmuga Subbiah, Arin Nam, Natasha Garg, et al.
Expert Opinion on Investigational Drugs|March 18, 2020
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trialsAtish Mohanty, Rebecca R Pharaon, Arin Nam, et al.
Advances in Cancer Research|June 29, 2020
MET receptor in oncology: From biomarker to therapeutic targetRaeva Malik, Isa Mambetsariev, Jeremy Fricke, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Oncotarget|May 8, 2018
Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patientsValeriy Poroyko, Tamara Mirzapoiazova, Arin Nam, et al.
JAMA Oncology|November 27, 2024
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A ReviewJyoti Malhotra, Isa Mambetsariev, Gregory Gilmore, et al.
Cancer Research|April 8, 2024
Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic PlasticityArin Nam, Shashi Jain, Chengsheng Wu, et al.
Iscience|November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell CarcinomasSaumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Pageof 3